Endovascular Engineering
95 employees on LinkedIn · 9 known investors
Find your way into Endovascular Engineering
Sign up to see every warm intro you have to Endovascular Engineering
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Endovascular Engineering team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Endovascular Engineering develops clot removal technologies targeting venous thromboembolism. The company serves the medical device and healthcare sectors.
Investors · 9
How we know: 415 Capital's portfolio page · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Norwest Venture Partners's portfolio page · Not right? Tell us
How we know: S3 Ventures's portfolio page · a partner's Signal profile · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMar 2025
415 Capital (lead), S3 Ventures (lead), Cordis, M&L Healthcare, Panakès Partners, Santé Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 6
Companies working in the same space as Endovascular Engineering.
In the news
Frequently asked questions
- What does Endovascular Engineering do?
- Endovascular Engineering develops clot removal technologies targeting venous thromboembolism. The company serves the medical device and healthcare sectors.
- Who are Endovascular Engineering's investors?
- Endovascular Engineering's investors include 415 Capital, Norwest Venture Partners, S3 Ventures, Gilde Healthcare, Panakes Partners.







